体质指数与肝硬度升高的风险之间的J形关系:一个横截面研究
Yuwei Liu1, Sheng Yuan1, Jing Zuo2
1Department of General Practice, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, Hubei, China.
European journal of medical research
|December 4, 2023
概括
异常的体重指数 (BMI),高和低,与增加肝硬度 (LS) 的更高风险有关. 这项研究确定了社区居民BMI和LS风险之间的J形关系.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 公共卫生 公共卫生
- 医学诊断 医学诊断 医学诊断
背景情况:
- 肝硬 (LS) 表示肝纤维化和肝硬化阶段.
- 之前关于身体质量指数 (BMI) 和LS的研究显示了相互矛盾的结果.
- 过渡性弹性学 (TE) 提供了一种非侵入性方法来评估LS.
研究的目的:
- 为了研究BMI和升高LS的风险之间的关系.
- 在一般社区人口中探索这种关联.
- 使用非侵入性TE技术进行LS测量.
主要方法:
- 包括5791名参与者,测量身高和体重以计算BMI.
- 使用肝硬度测量 (LSM) 的切线>9.1 kPa.
- 使用通用线性回归和细分回归模型来分析BMI-LS风险和值效应.
主要成果:
- 230名参与者 (3.97%) 患有TE检测到的升高的LS.
- 在对混因素进行调整后,在BMI和LS风险升高之间观察到J形关系.
- 转折点是BMI为23.05kg/m2,双方都有增加的风险.
结论:
- 确定了BMI和LS风险升高之间的新型J形关联.
- 体重不足和体重过重/肥胖的BMI值都与增加的LS风险相关.
- 这凸显了维持健康的BMI对肝脏健康的重要性.
相关概念视频
Diseases of the Liver and Gallbladder
560
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
560
Liver Physiology
569
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
569
Ultrasound II: Endoscopic Ultrasound and FibroScan
113
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
113
Gross Anatomy of the Liver
448
The liver, the largest gland within the human body, is a firm and reddish-brown organ. This wedge-shaped structure weighs approximately 1.5 kg and occupies a significant portion of the right hypochondriac and epigastric regions. It extends more to the right of the body's midline than to the left.
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is...
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is...
448
Hepatic Drug Clearance: Effect of Protein Binding
210
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
210
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
124
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
124


